Imagabalin, formerly known as PD0332334 and PF-00195889, is a drug which acts as a ligand for the α2δ subunit of the voltage-dependent calcium channel, with some selectivity for the α2δ1 subunit over α2δ2. Imagabalin has demonstrated preclinical efficacy of anxiolytic, analgesic, hypnotic, and anticonvulsant-like activity and is currently in phase III clinical trials for the treatment of generalized anxiety disorder. References: Dunn AL, Codina A, Foley DA, Marquez BL, Zell MT. A detailed mechanistic investigation into the reaction of 3-methylpentanoic acid with Meldrum's acid utilizing online NMR spectroscopy. Magn Reson Chem. 2015 Aug 31. doi: 10.1002/mrc.4317. [Epub ahead of print] PubMed PMID: 26332370.

纯度：≥98%

CAS：610300-07-7